Human CD177 PharmaGenie ELISA Kit (SBRS0366)

Assay Genie's CD177 quantitative immunoassay targets the neutrophil-specific glycoprotein CD177, a GPI-anchored surface marker selectively expressed on a subset of circulating neutrophils. The kit supports research into myeloproliferative neoplasms, ANCA-associated vasculitis, inflammatory bowel disease, and neutrophil extravasation, where CD177 interaction with endothelial PECAM1 is a key area of investigation.

Researchers employ this assay to monitor CD177 shedding during neutrophil activation and to characterize its overexpression in polycythemia vera and essential thrombocythemia. Reconstituted standards and detection antibody should be aliquoted and stored frozen to limit freeze-thaw cycles, while the microplate and unused strips remain refrigerated at 4 degrees C. All components are supplied for research use only by Assay Genie.